Stemline Therapeutics' Debt Round

Stemline Therapeutics raised a round of funding on January 18, 2012.

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology therapeutics that target cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates ar…

Articles about Stemline Therapeutics' Debt Round: